Skip to content

13F-HR filed by ORACLE INVESTMENT MANAGEMENT INC

ORACLE INVESTMENT MANAGEMENT INC filed this 13F-HR for the quarter ended 2014-03-31, filed 2014-05-15, with 30 holding rows worth $875,576,705.

Accession
0001085146-14-001204
Filed
2014-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2014

A holdings report, 30 entries on the cover page, a total value of $875,576,705 stated on the cover page (in dollars after the unit check, H1), rows summing to $875,576,705 with VALUE read as dollars, detected, 13F file number 028-05592. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Accelerate Diagnostics00430H102COM4,778,049$104,209,249dollars, detected
QUIDEL CORP74838J101COM3,256,957$88,914,926dollars, detected
TENET HEALTHCARE CORP COM NEW88033G407Stock1,755,950$75,172,219dollars, detected
ACORDA THERAPEUTICS INC00484M106COM1,956,414$74,167,655dollars, detected
MAZOR ROBOTICS LTD57886P103SPONSORED ADS3,194,562$65,296,847dollars, detected
THORATEC CORP885175307COM1,756,204$62,889,665dollars, detected
OPKO HEALTH INC68375N103COM5,571,960$51,930,667dollars, detected
HANSEN MEDICAL INC411307101COM19,658,147$51,111,182dollars, detected
NXSTAGE MEDICAL INC67072V103COMMON STOCK3,599,192$45,853,706dollars, detected
Transition Therapeutics, Inc.893716209COM4,287,412$34,170,674dollars, detected
ACCURAY INC DEL004397105COM3,240,006$31,104,058dollars, detected
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK1,846,005$22,742,782dollars, detected
REPROS THERAPEUTICS INC76028H209COM1,242,326$22,038,863dollars, detected
VERMILLION INC92407M206COM NEW7,139,960$21,062,882dollars, detected
TESARO INC881569107COM633,752$18,683,009dollars, detected
ENDOCYTE INC29269A102COM670,000$15,952,700dollars, detected
BIOLASE INC090911108COMMON STOCK6,135,910$14,787,543dollars, detected
INTREXON CORP46122T102COM550,000$14,459,500dollars, detected
PACIFIC BIOSCIENCES CALIF INC COM69404D108Stock2,575,729$13,780,150dollars, detected
WEBMD HEALTH CORP94770V102COM300,141$12,425,837dollars, detected
GENTIVA HEALTH SERVICES37247A102COM847,600$7,730,112dollars, detected
DERMA SCIENCES INC249827502COM PAR $.01500,000$6,340,000dollars, detected
AMARIN CORP PLC023111206SPONS ADR NEW3,000,000$5,430,000dollars, detected
AGENUS INC00847G705COM NEW1,375,634$4,360,763dollars, detected
AGIOS PHARMACEUTICALS INC00847X104COM100,000$3,915,000dollars, detected
BIOGEN INC COM09062X103Stock11,530$3,526,681dollars, detected
METABOLIX INC591018809COM1,658,126$2,155,564dollars, detected
GTX INC40052B108COM497,769$761,587dollars, detected
LADENBURG THALMANN FINANCIAL50575Q102COM166,849$503,884dollars, detected
Gilead Sciences,Inc.375558103COM50,000$99,000dollars, detected

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001085146-14-001204this filing2014-05-15acceptance time not in the bulk data set